112 related articles for article (PubMed ID: 15845375)
1. Emergence of nuclear heparanase induces differentiation of human mammary cancer cells.
Nobuhisa T; Naomoto Y; Takaoka M; Tabuchi Y; Ookawa K; Kitamoto D; Gunduz E; Gunduz M; Nagatsuka H; Haisa M; Matsuoka J; Nakajima M; Tanaka N
Biochem Biophys Res Commun; 2005 May; 331(1):175-80. PubMed ID: 15845375
[TBL] [Abstract][Full Text] [Related]
2. Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage.
Kobayashi M; Naomoto Y; Nobuhisa T; Okawa T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Mizushima T; Matsuura H; Nakajima M; Nakagawa H; Rustgi A; Tanaka N
Differentiation; 2006 Jun; 74(5):235-43. PubMed ID: 16759289
[TBL] [Abstract][Full Text] [Related]
3. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
4. COX-2 induction by heparanase in the progression of breast cancer.
Imada T; Matsuoka J; Nobuhisa T; Okawa T; Murata T; Tabuchi Y; Shirakawa Y; Ohara N; Gunduz M; Nagatsuka H; Umeoka T; Yamamoto Y; Nakajima M; Tanaka N; Naomoto Y
Int J Mol Med; 2006 Feb; 17(2):221-8. PubMed ID: 16391819
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways in intestinal development and cancer.
Sancho E; Batlle E; Clevers H
Annu Rev Cell Dev Biol; 2004; 20():695-723. PubMed ID: 15473857
[TBL] [Abstract][Full Text] [Related]
6. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
7. A new targeting approach for breast cancer gene therapy using the heparanase promoter.
Breidenbach M; Rein DT; Schöndorf T; Khan KN; Herrmann I; Schmidt T; Reynolds PN; Vlodavsky I; Haviv YS; Curiel DT
Cancer Lett; 2006 Aug; 240(1):114-22. PubMed ID: 16271435
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer.
Cohen I; Maly B; Simon I; Meirovitz A; Pikarsky E; Zcharia E; Peretz T; Vlodavsky I; Elkin M
Clin Cancer Res; 2007 Jul; 13(14):4069-77. PubMed ID: 17634531
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of silencing heparanase expression with antisense oligodeoxynucleotide on invasive capability of human esophageal squamous cancer cell line TE-13].
Zhu H; Wang SJ; Wang SX; Meng XL; Wang YJ
Ai Zheng; 2005 Dec; 24(12):1431-5. PubMed ID: 16351787
[TBL] [Abstract][Full Text] [Related]
10. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2.
Okawa T; Naomoto Y; Nobuhisa T; Takaoka M; Motoki T; Shirakawa Y; Yamatsuji T; Inoue H; Ouchida M; Gunduz M; Nakajima M; Tanaka N
Clin Cancer Res; 2005 Nov; 11(22):7995-8005. PubMed ID: 16299228
[TBL] [Abstract][Full Text] [Related]
11. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
12. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
13. Involvement of disulfide bond formation in the activation of heparanase.
Simizu S; Suzuki T; Muroi M; Lai NS; Takagi S; Dohmae N; Osada H
Cancer Res; 2007 Aug; 67(16):7841-9. PubMed ID: 17699790
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies.
He X; Brenchley PE; Jayson GC; Hampson L; Davies J; Hampson IN
Cancer Res; 2004 Jun; 64(11):3928-33. PubMed ID: 15173004
[TBL] [Abstract][Full Text] [Related]
15. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.
Ogishima T; Shiina H; Breault JE; Terashima M; Honda S; Enokida H; Urakami S; Tokizane T; Kawakami T; Ribeiro-Filho LA; Fujime M; Kane CJ; Carroll PR; Igawa M; Dahiya R
Oncogene; 2005 Oct; 24(45):6765-72. PubMed ID: 16007175
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of siRNA on heparanase expression and invasion ability of gastric cancer cells: an in vitro experiment].
Zhang Y; Wang ZN; Zhang X; Xu HM; Jiang L; Luo Y; Xing LL; Xu MD; Li J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1717-20. PubMed ID: 17825158
[TBL] [Abstract][Full Text] [Related]
17. Function of heparanase in prostate tumorigenesis: potential for therapy.
Lerner I; Baraz L; Pikarsky E; Meirovitz A; Edovitsky E; Peretz T; Vlodavsky I; Elkin M
Clin Cancer Res; 2008 Feb; 14(3):668-76. PubMed ID: 18212251
[TBL] [Abstract][Full Text] [Related]
18. Heparanase, tissue factor, and cancer.
Nadir Y; Vlodavsky I; Brenner B
Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
[TBL] [Abstract][Full Text] [Related]
19. Human heparanase nuclear localization and enzymatic activity.
Schubert SY; Ilan N; Shushy M; Ben-Izhak O; Vlodavsky I; Goldshmidt O
Lab Invest; 2004 May; 84(5):535-44. PubMed ID: 15034597
[TBL] [Abstract][Full Text] [Related]
20. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma.
Davidson B; Shafat I; Risberg B; Ilan N; Trope' CG; Vlodavsky I; Reich R
Gynecol Oncol; 2007 Feb; 104(2):311-9. PubMed ID: 17030350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]